FDA Defends Ephedra Ban Procedures In Nutraceutical Case Filing
This article was originally published in The Tan Sheet
Executive Summary
FDA followed required rulemaking procedures in issuing a final rule that banned ephedra dietary supplements, the agency argues in a response brief filed in its ongoing legal battle with Nutraceutical Corp